Herceptin Hylecta and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Herceptin Hylecta and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Herceptin Hylecta-Moxifloxacin
- Herceptin Hylecta-Moxifloxacin (Systemic)
- Herceptin Hylecta-Moxifloxacin Hydrochloride
- Herceptin Hylecta-Moxifloxacin Injection
- Herceptin Hylecta-Moxifloxacin Intravenous
- Herceptin Hylecta-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Hermes No. 8
- Moxetumomab pasudotox-tdfk Intravenous-Herzuma
- Moxetumomab pasudotox-tdfk Intravenous-Hetlioz
- Moxetumomab pasudotox-tdfk Intravenous-Hexabrix
- Moxetumomab pasudotox-tdfk Intravenous-Hexachlorophene
- Moxetumomab pasudotox-tdfk Intravenous-Hexachlorophene Topical application